Responses
Hepatology
Original article
Favouring modulation of circulating lipoproteins and lipid loading capacity by direct antiviral agents grazoprevir/elbasvir or ledipasvir/sofosbuvir treatment against chronic HCV infection
Compose a Response to This Article
Other responses
No responses have been published for this article.